Nevro Corp. (NVRO): Price and Financial Metrics

Nevro Corp. (NVRO): $121.29

1.02 (+0.85%)

POWR Rating

Component Grades














  • NVRO scores best on the Quality dimension, with a Quality rank ahead of 67.16% of US stocks.
  • NVRO's strongest trending metric is Quality; it's been moving up over the last 52 weeks.
  • NVRO's current lowest rank is in the Stability metric (where it is better than 15.73% of US stocks).

NVRO Stock Summary

  • Price to trailing twelve month operating cash flow for NVRO is currently 354.31, higher than 98.84% of US stocks with positive operating cash flow.
  • NVRO's price/sales ratio is 10.25; that's higher than the P/S ratio of 82.35% of US stocks.
  • With a year-over-year growth in debt of -48.87%, Nevro Corp's debt growth rate surpasses merely 9.89% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Nevro Corp are EKSO, ECOR, BXRX, LMND, and STIM.
  • Visit NVRO's SEC page to see the company's official filings. To visit the company's web site, go to

NVRO Valuation Summary

  • In comparison to the median Healthcare stock, NVRO's price/sales ratio is 8.37% lower, now standing at 10.4.
  • Over the past 83 months, NVRO's EV/EBIT ratio has gone down 79.7.
  • Over the past 83 months, NVRO's price/sales ratio has gone down 11.2.

Below are key valuation metrics over time for NVRO.

Stock Date P/S P/B P/E EV/EBIT
NVRO 2021-08-31 10.4 11.9 -62.3 -101.4
NVRO 2021-08-30 10.1 11.6 -60.7 -98.8
NVRO 2021-08-27 10.1 11.6 -60.8 -99.0
NVRO 2021-08-26 9.8 11.2 -58.6 -95.4
NVRO 2021-08-25 9.7 11.1 -58.4 -95.1
NVRO 2021-08-24 9.9 11.3 -59.1 -96.2

NVRO Growth Metrics

  • Its 3 year net cashflow from operations growth rate is now at 81.4%.
  • The year over year net cashflow from operations growth rate now stands at 98.52%.
  • Its year over year net income to common stockholders growth rate is now at -3.83%.
NVRO's revenue has moved up $131,223,000 over the prior 49 months.

The table below shows NVRO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 409.131 11.835 -68.265
2021-03-31 363.191 -0.499 -87.738
2020-12-31 362.048 1.191 -83.065
2020-09-30 366.691 -24.143 -89.678
2020-06-30 358.393 -38.852 -97.54
2020-03-31 395.574 -33.699 -84.498

NVRO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NVRO has a Quality Grade of C, ranking ahead of 67.16% of graded US stocks.
  • NVRO's asset turnover comes in at 0.556 -- ranking 81st of 186 Medical Equipment stocks.
  • CSII, XENT, and KRMD are the stocks whose asset turnover ratios are most correlated with NVRO.

The table below shows NVRO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.556 0.700 -0.058
2021-03-31 0.469 0.693 -0.084
2020-12-31 0.521 0.690 -0.093
2020-09-30 0.596 0.690 -0.124
2020-06-30 0.673 0.689 -0.160
2020-03-31 0.867 0.697 -0.146

NVRO Stock Price Chart Interactive Chart >

Price chart for NVRO

NVRO Price/Volume Stats

Current price $121.29 52-week high $188.14
Prev. close $120.27 52-week low $99.54
Day low $118.36 Volume 300,900
Day high $121.66 Avg. volume 468,186
50-day MA $118.13 Dividend yield N/A
200-day MA $146.83 Market Cap 4.23B

Nevro Corp. (NVRO) Company Bio

Nevro Corporation develops and commercializes a neuromodulation platform for the treatment of chronic pain. The company was founded in 2006 and is founded in Menlo Park, California.

NVRO Latest News Stream

Event/Time News Detail
Loading, please wait...

NVRO Latest Social Stream

Loading social stream, please wait...

View Full NVRO Social Stream

Latest NVRO News From Around the Web

Below are the latest news stories about Nevro Corp that investors may wish to consider to help them evaluate NVRO as an investment opportunity.

Hedge Funds Aren’t Crazy About Nevro Corp (NVRO) Anymore

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]

Yahoo | October 19, 2021

Nevro to Report Third Quarter 2021 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the third quarter ended September 30, 2021 after the market closes on November 8, 2021.

Yahoo | October 11, 2021

Why Is Nevro (NVRO) Up 8.6% Since Last Earnings Report?

Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 3, 2021

Nevro Announces Director Appointment

Nevro Corp. (NYSE: NVRO), a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, today announced that Sri Kosaraju has been appointed as a member of the Board of Directors (the "Board"), effective August 31, 2021.

Yahoo | August 31, 2021

Nevro to Present at Baird 2021 Global Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the Baird 2021 Global Healthcare Conference on Wednesday, September 15, 2021 at 10:50 am Eastern Time / 7:50 am Pacific Time.

Yahoo | August 26, 2021

Read More 'NVRO' Stories Here

NVRO Price Returns

1-mo -0.55%
3-mo -21.28%
6-mo -26.97%
1-year -25.08%
3-year 155.35%
5-year 21.12%
YTD -29.93%
2020 47.27%
2019 202.24%
2018 -43.67%
2017 -4.98%
2016 7.63%

Continue Researching NVRO

Here are a few links from around the web to help you further your research on Nevro Corp's stock as an investment opportunity:

Nevro Corp (NVRO) Stock Price | Nasdaq
Nevro Corp (NVRO) Stock Quote, History and News - Yahoo Finance
Nevro Corp (NVRO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0119 seconds.